Wells Fargo & Company Ovid Therapeutics Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 743,807 shares of OVID stock, worth $267,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares

743,807

Previous 735,185 1.17%

Holding current value

$267,770

Previous $867,000 20.3%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$0.93 - $1.36 $8,018 - $11,725	8,622 Added 1.17%	743,807 $691,000
Q3 2024 Nov 13, 2024	SELL	$0.75 - $1.3 $4,841 - $8,391	-6,455 Reduced 0.87%	735,185 $867,000
Q2 2024 Aug 13, 2024	BUY	$0.7 - $3.34 $215,437 - $1.03 Million	307,768 Added 70.94%	741,640 $571,000
Q1 2024 May 10, 2024	SELL	$2.72 - $4.04 $40,035 - $59,464	-14,719 Reduced 3.28%	433,872 $1.32 Million
Q4 2023 Feb 09, 2024	BUY	$2.98 - $3.78 $10,802 - $13,702	3,625 Added 0.81%	448,591 $1.44 Million
Q3 2023 Nov 13, 2023	SELL	$3.23 - $3.97 $19,383 - $23,823	-6,001 Reduced 1.33%	444,966 $1.71 Million
Q2 2023 Aug 15, 2023	BUY	$2.53 - $3.89 $51,374 - $78,990	20,306 Added 4.72%	450,967 $1.48 Million
Q1 2023 May 12, 2023	BUY	$1.88 - $2.85 $2,829 - $4,289	1,505 Added 0.35%	430,661 $1.11 Million
Q4 2022 Feb 13, 2023	SELL	$1.43 - $1.89 $8,099 - $10,704	-5,664 Reduced 1.3%	429,156 $798,000
Q3 2022 Nov 14, 2022	BUY	$1.84 - $2.26 $5,186 - $6,370	2,819 Added 0.65%	434,820 $800,000
Q2 2022 Aug 12, 2022	SELL	$1.69 - $3.31 $4,819 - $9,440	-2,852 Reduced 0.66%	432,001 $929,000
Q1 2022 May 16, 2022	SELL	$2.65 - $3.49 $46,412 - $61,123	-17,514 Reduced 3.87%	434,853 $1.37 Million
Q4 2021 Feb 14, 2022	SELL	$3.13 - $3.73 $5,477 - $6,527	-1,750 Reduced 0.39%	452,367 $1.45 Million
Q3 2021 Nov 15, 2021	BUY	$3.31 - $4.04 $1,655 - $2,020	500 Added 0.11%	454,117 $1.53 Million
Q2 2021 Aug 16, 2021	SELL	$3.3 - $4.49 $15,404 - $20,959	-4,668 Reduced 1.02%	453,617 $1.77 Million
Q1 2021 May 13, 2021	SELL	$2.42 - $4.47 $226,207 - $417,828	-93,474 Reduced 16.94%	458,285 $1.84 Million
Q4 2020 Feb 09, 2021	BUY	$2.28 - $6.84 $38,014 - $114,043	16,673 Added 3.12%	551,759 $1.27 Million
Q3 2020 Nov 05, 2020	BUY	$5.39 - $8.24 $78,968 - $120,724	14,651 Added 2.82%	535,086 $3.07 Million
Q2 2020 Aug 13, 2020	BUY	$2.67 - $7.91 $81,739 - $242,156	30,614 Added 6.25%	520,435 $3.84 Million
Q1 2020 May 14, 2020	BUY	$2.03 - $4.35 $994,336 - $2.13 Million	489,821 New	489,821 $1.46 Million

Others Institutions Holding OVID

# of Institutions

Shares Held

40.7M

Call Options Held

2.4K

Put Options Held

200

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $25.4M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ovid Therapeutics Inc. Transaction History